Back to News
Market Impact: 0.35
Disc Medicine Prices $450 Mln Offering Of Shares At $75/shr To Fund Pipeline Development
Source: Nasdaq
Healthcare & BiotechIPOs & SPACsCompany Fundamentals
Disc Medicine priced an upsized underwritten public offering of 6 million common shares at $75.00 per share, implying aggregate gross proceeds of $450 million. The share issuance provides capital but may dilute existing shareholders; the provided article text does not state net proceeds or intended use.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
IRON0.10
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- Jio IPO Sees Overwhelming Demand on Day One Even as Nifty Struggles
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Why is Tesla stock falling after-hours today?
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal